Ticker Symbol: NTILF
Neurotech International Limited
Exchange: US OTC
Currency:
USD
Asset
Type: Common Stock
Company Profile
Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. It offers a portable electroencephalogram medical device that uses neurofeedback to help relax the minds of children with autism spectrum disorder. The company was founded by Adrian Attard Trevisan on January 15, 2016 and is headquartered in Perth, Australia.
Sector: Health Technology
Industry: Medical Specialties
Standard Industrial Classification Code (SIC code): 3841
Address: N/A
CEO: Peter J. L. Griffiths
Tags:
- Medical Specialties
- Health Technology
Pricing
Last Updated: December 31, 1969 07:00 PM EST
Previous Close: -
Change:
-
(
0.00%)
Days Range: - - -
Beta: -
52wk. High: -
52wk. Low: -
Ytd. Change 0.00%
50 Day Moving Average: -
200 Day Moving Average: -
Shares Outstanding: 697699126
Valuation
Market Cap: -
PE Ratio: -
EPS (TTM): 0
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A